Deficiency of dimeric IgA1 in the serum of patients with IgA Nephropathy (IgAN)

R. L. Quillin, D. K. Hammond, S. C. Diven, R. M. Goldblum

Research output: Contribution to journalArticle

Abstract

IgA nephropathy is the most common primary cause of glomerulonephritis worldwide. Approximately 20-30% of patients develop chronic renal failure, requiring dialysis and/or transplantation. The histological hallmark of the disease is deposition of IgA1 (including dimers) in the mesangium of the kidney. Total IgA in the serum is also increased in about half of the patients and increased levels of large IgA-containing complexes have also been described in IgAN sera. In order to elucidate the relationship between abnormalities in circulating IgA and the renal pathology, we have compared the distribution of molecular size forms of IgA1 in the sera of patients with IgAN with those from normal controls. Total IgA1 was first isolated using jacalin-agarose chromatography. The eluted IgA was subjected to HPLC molecular sieve chromatography (Pharmacia HR200). The relative proportion of monomeric, dimer, and polymeric IgA1 were calculated from the HPLC chromatograms. The results are shown below: Monomeric Dimeric Polymeric (*mean ± 1 S.D.) IgAN patients (n=16) *79.6 ± 5.5 7.8 ± 2.3 12.6 ± 5.7 Normal controls (n=14) 76.7 ± 6.1 13.9 ± 5.3 9.5 ± 3.4 P values 0.19 0.001 0.092 The proportion of IgA that was monomeric was the same in the sera from the IgAN patients and controls. However, the proportion of dimers in the patient sera was decreased and the proportion of polymers was more variable among the patient sera than among the normal sera. The deficits in dimeric IgA1 may be due to enhanced incorporation into polymeric complexes or disproportionate sequestration in the kidney. Since dimeric has been shown to inhibit activation of some inflammatory cells, the deficit in circulating IgA may allow pathologic activation of mesangial cells in the kidney of patients with IgAN.

Original languageEnglish (US)
JournalJournal of Investigative Medicine
Volume47
Issue number2
StatePublished - Feb 1999

Fingerprint

Immunoglobulin A
Serum
Dimers
Chromatography
Kidney
Chemical activation
High Pressure Liquid Chromatography
Agarose Chromatography
Mesangial Cells
Dialysis
Molecular sieves
Pathology
Glomerulonephritis
Sepharose
Chronic Kidney Failure
Gel Chromatography
Polymers

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Quillin, R. L., Hammond, D. K., Diven, S. C., & Goldblum, R. M. (1999). Deficiency of dimeric IgA1 in the serum of patients with IgA Nephropathy (IgAN). Journal of Investigative Medicine, 47(2).

Deficiency of dimeric IgA1 in the serum of patients with IgA Nephropathy (IgAN). / Quillin, R. L.; Hammond, D. K.; Diven, S. C.; Goldblum, R. M.

In: Journal of Investigative Medicine, Vol. 47, No. 2, 02.1999.

Research output: Contribution to journalArticle

Quillin, RL, Hammond, DK, Diven, SC & Goldblum, RM 1999, 'Deficiency of dimeric IgA1 in the serum of patients with IgA Nephropathy (IgAN)', Journal of Investigative Medicine, vol. 47, no. 2.
Quillin, R. L. ; Hammond, D. K. ; Diven, S. C. ; Goldblum, R. M. / Deficiency of dimeric IgA1 in the serum of patients with IgA Nephropathy (IgAN). In: Journal of Investigative Medicine. 1999 ; Vol. 47, No. 2.
@article{513a5a255a9c452184d454e6b57a185a,
title = "Deficiency of dimeric IgA1 in the serum of patients with IgA Nephropathy (IgAN)",
abstract = "IgA nephropathy is the most common primary cause of glomerulonephritis worldwide. Approximately 20-30{\%} of patients develop chronic renal failure, requiring dialysis and/or transplantation. The histological hallmark of the disease is deposition of IgA1 (including dimers) in the mesangium of the kidney. Total IgA in the serum is also increased in about half of the patients and increased levels of large IgA-containing complexes have also been described in IgAN sera. In order to elucidate the relationship between abnormalities in circulating IgA and the renal pathology, we have compared the distribution of molecular size forms of IgA1 in the sera of patients with IgAN with those from normal controls. Total IgA1 was first isolated using jacalin-agarose chromatography. The eluted IgA was subjected to HPLC molecular sieve chromatography (Pharmacia HR200). The relative proportion of monomeric, dimer, and polymeric IgA1 were calculated from the HPLC chromatograms. The results are shown below: Monomeric Dimeric Polymeric (*mean ± 1 S.D.) IgAN patients (n=16) *79.6 ± 5.5 7.8 ± 2.3 12.6 ± 5.7 Normal controls (n=14) 76.7 ± 6.1 13.9 ± 5.3 9.5 ± 3.4 P values 0.19 0.001 0.092 The proportion of IgA that was monomeric was the same in the sera from the IgAN patients and controls. However, the proportion of dimers in the patient sera was decreased and the proportion of polymers was more variable among the patient sera than among the normal sera. The deficits in dimeric IgA1 may be due to enhanced incorporation into polymeric complexes or disproportionate sequestration in the kidney. Since dimeric has been shown to inhibit activation of some inflammatory cells, the deficit in circulating IgA may allow pathologic activation of mesangial cells in the kidney of patients with IgAN.",
author = "Quillin, {R. L.} and Hammond, {D. K.} and Diven, {S. C.} and Goldblum, {R. M.}",
year = "1999",
month = "2",
language = "English (US)",
volume = "47",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Deficiency of dimeric IgA1 in the serum of patients with IgA Nephropathy (IgAN)

AU - Quillin, R. L.

AU - Hammond, D. K.

AU - Diven, S. C.

AU - Goldblum, R. M.

PY - 1999/2

Y1 - 1999/2

N2 - IgA nephropathy is the most common primary cause of glomerulonephritis worldwide. Approximately 20-30% of patients develop chronic renal failure, requiring dialysis and/or transplantation. The histological hallmark of the disease is deposition of IgA1 (including dimers) in the mesangium of the kidney. Total IgA in the serum is also increased in about half of the patients and increased levels of large IgA-containing complexes have also been described in IgAN sera. In order to elucidate the relationship between abnormalities in circulating IgA and the renal pathology, we have compared the distribution of molecular size forms of IgA1 in the sera of patients with IgAN with those from normal controls. Total IgA1 was first isolated using jacalin-agarose chromatography. The eluted IgA was subjected to HPLC molecular sieve chromatography (Pharmacia HR200). The relative proportion of monomeric, dimer, and polymeric IgA1 were calculated from the HPLC chromatograms. The results are shown below: Monomeric Dimeric Polymeric (*mean ± 1 S.D.) IgAN patients (n=16) *79.6 ± 5.5 7.8 ± 2.3 12.6 ± 5.7 Normal controls (n=14) 76.7 ± 6.1 13.9 ± 5.3 9.5 ± 3.4 P values 0.19 0.001 0.092 The proportion of IgA that was monomeric was the same in the sera from the IgAN patients and controls. However, the proportion of dimers in the patient sera was decreased and the proportion of polymers was more variable among the patient sera than among the normal sera. The deficits in dimeric IgA1 may be due to enhanced incorporation into polymeric complexes or disproportionate sequestration in the kidney. Since dimeric has been shown to inhibit activation of some inflammatory cells, the deficit in circulating IgA may allow pathologic activation of mesangial cells in the kidney of patients with IgAN.

AB - IgA nephropathy is the most common primary cause of glomerulonephritis worldwide. Approximately 20-30% of patients develop chronic renal failure, requiring dialysis and/or transplantation. The histological hallmark of the disease is deposition of IgA1 (including dimers) in the mesangium of the kidney. Total IgA in the serum is also increased in about half of the patients and increased levels of large IgA-containing complexes have also been described in IgAN sera. In order to elucidate the relationship between abnormalities in circulating IgA and the renal pathology, we have compared the distribution of molecular size forms of IgA1 in the sera of patients with IgAN with those from normal controls. Total IgA1 was first isolated using jacalin-agarose chromatography. The eluted IgA was subjected to HPLC molecular sieve chromatography (Pharmacia HR200). The relative proportion of monomeric, dimer, and polymeric IgA1 were calculated from the HPLC chromatograms. The results are shown below: Monomeric Dimeric Polymeric (*mean ± 1 S.D.) IgAN patients (n=16) *79.6 ± 5.5 7.8 ± 2.3 12.6 ± 5.7 Normal controls (n=14) 76.7 ± 6.1 13.9 ± 5.3 9.5 ± 3.4 P values 0.19 0.001 0.092 The proportion of IgA that was monomeric was the same in the sera from the IgAN patients and controls. However, the proportion of dimers in the patient sera was decreased and the proportion of polymers was more variable among the patient sera than among the normal sera. The deficits in dimeric IgA1 may be due to enhanced incorporation into polymeric complexes or disproportionate sequestration in the kidney. Since dimeric has been shown to inhibit activation of some inflammatory cells, the deficit in circulating IgA may allow pathologic activation of mesangial cells in the kidney of patients with IgAN.

UR - http://www.scopus.com/inward/record.url?scp=33750103046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750103046&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750103046

VL - 47

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 2

ER -